Zimmer Biomet Holdings, Inc. today announced that members of the Executive Management Team will be presenting at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 10:30 a.m. Eastern Time and at the J.P. Morgan 13th Annual U.S. All Stars Conference.
|
WARSAW, Ind., Aug. 29, 2022 /PRNewswire/ -- Zimmer Biomet (Formerly Known As Biomet Inc.) Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Executive Management Team will be presenting at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 10:30 a.m. Eastern Time and at the J.P. Morgan 13th Annual U.S. All Stars Conference on Tuesday, September 20, 2022, at 14:00 British Summer Time (9:00 a.m. Eastern Time).
A live webcast of the presentations can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. The webcasts will be archived for replay following the conference. About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet. ZBH-Con
SOURCE Zimmer Biomet Holdings, Inc. |
|||||||||||||||||
Company Codes: NYSE:ZBH, Swiss:ZBH |
View original content to download multimedia:
